RCM
AEON.WS

Radcliffe Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Radcliffe Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-139,840
Closed -$12.2K – 170
2023
Q4 		$12.2K Sell
139,840
-127,790
-48% -$9.53K ﹤0.01% 131
2023
Q3 		$42.8K Sell
267,630
-21,199
-7% -$3.01K 0.01% 211
2023
Q2 		$24.6K Hold
288,829
– – ﹤0.01% 308
2023
Q1 		$18.9K Hold
288,829
– – ﹤0.01% 435
2022
Q4 		$2.9M Hold
288,829
– – 0.09% 352
2022
Q3 		$2.85M Hold
288,829
– – 0.07% 490
2022
Q2 		$2.83M Hold
288,829
– – 0.07% 519
2022
Q1 		$2.83M Hold
288,829
– – 0.06% 497
2021
Q4 		$2.81M Hold
288,829
– – 0.07% 425
2021
Q3 		$2.81M Hold
288,829
– – 0.08% 367
2021
Q2 		$2.78M Buy
+288,829
New +$219K 0.09% 381

Other funds holding AEON.WS

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Radcliffe Capital Management's AEON.WS Position: Q1 2024 in Review

Radcliffe Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q1 2024, closing a stake of 139,840 shares — an estimated $12.2K sold.

Radcliffe Capital Management first reported a position in AEON.WS in Q2 2021 and held it in 11 quarters. The position peaked at $2.9M in Q4 2022. 30 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2024.

  • Radcliffe Capital Management reported no remaining AEON Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Radcliffe Capital Management sold 139,840 AEON Biopharma Inc shares in Q1 2024, an estimated $12.2K.
  • Radcliffe Capital Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 11 quarters.
  • Radcliffe Capital Management's AEON Biopharma Inc position peaked at $2.9M in Q4 2022.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2024.

Based on Radcliffe Capital Management's 13F filing for Q1 2024, filed 15 May 2024.